Feb 14 (Reuters)-
Cosmo Bio Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2021 Dec 31, 2020 Dec 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 9.23 8.09 9.40 4.90
(+14.1 pct) (+6.6 pct)
Operating 1.05 752 mln 830 mln 580 mln
(+39.4 pct) (+85.6 pct) (-20.9 pct) (-19.1 pct)
Recurring 1.10 817 mln 870 mln 610 mln
(+34.5 pct) (+73.7 pct) (-20.9 pct) (-18.9 pct)
Net
Net 737 mln 674 mln 580 mln 400 mln
(+9.4 pct) (+183.2 pct) (-21.3 pct) (-18.4 pct)
EPS 126.94 yen 113.70 yen 100.14 yen 69.06 yen
Ann Div 36.00 yen 34.00 yen 36.00 yen
-Q2 Div 12.00 yen 8.00 yen 16.00 yen
-Q4 Div 24.00 yen 26.00 yen 20.00 yen
NOTE - Cosmo Bio Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T